Clinical factors associated with shock in bacteremic UTI

International Urology and Nephrology

Volumn 45, Issue 3, 2013, Pages 653-657

  Shigemura, Katsumi ^a   Tanaka, Kazushi ^a   Osawa, Kayo ^b   Arakawa, Sochi ^a,b   Miyake, Hideaki ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bacteremia; Clinical factors associated with bacteremic shock; Shock; Urinary tract infection

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; DECISION MAKING; DISEASE ASSOCIATION; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INDWELLING URINARY CATHETER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTOR; SHOCK; SYSTOLIC BLOOD PRESSURE; URINARY TRACT INFECTION; UROLOGY;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SHOCK; SURVIVAL RATE; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84879503794     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0449-4     Document Type: Article

References (26)

1. Bader MS, Hawboldt J, Brooks A (2010) Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med 122:7-15
2. Matsumoto T (2001) Urinary tract infections in the elderly. Curr Urol Rep 2:330-333
3. Ronald A (2003) The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 49:71-82
4. Heyns CF (2012) Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World J Urol 30:77-83
5. Brown PD (2010) Management of urinary tract infections associated with nephrolithiasis. Curr Infect Dis Rep 12:450-454
6. Geerlings SE (2008) Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 31:S54-S57
7. Geerlings SE, Stolk RP, Camps MJ et al (2000) Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 23:744-749
8. Lever A, Mackenzie I (2007) Sepsis: definition, epidemiology, and diagnosis. BMJ 335:879-883
9. Shubin H, Weil MH (1976) Bacterial shock. JAMA 235:421-424
10. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septicshock, 2012. Intensive Care Med 39:165-228
11. Clinical and Laboratory Standards Institute (2008) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard 8th edition. Document M07-A8 CLSI, Wayne, PA
12. YokooA Kumamoto Y, Hirose T (1994) Study on intractable factors in urinary tract infections-multiple regression analysis. Kansenshogaku Zasshi 68:905-915
13. Nicolle LE (2008) Short-term therapy for urinary tract infection: success and failure. Int J Antimicrob Agents 31:S40-S45
14. Shigemura K, Arakawa S, Tanaka K et al (2009) Clinical investigation of isolated bacteria from urinary tracts of hospitalized patients and their susceptibilities to antibiotics. J Infect Chemother 15:18-22
15. Wagenlehner FM, Pilatz A, Weidner W (2011) Urosepsis-from the view of the urologist. Int J Antimicrob Agents 38:S51-S57
16. Hori J, Yamaguchi S, Watanabe M et al (2008) Clinical investigation of extracorporeal endotoxin adsorption therapy in septic urinary tract infections. Nihon Hinyokika Gakkai Zasshi 99:578-583
17. Guzmàn CA, Pruzzo C, LiPira G et al (1989) Role of adherence in pathogenesis of Enterococcus faecalis urinary tract infection and endocarditis. Infect Immun 57:1834-1838
18. Tabibian JH, Gornbein J, Heidari A et al (2008) Uropathogens and host characteristics. J Clin Microbiol 46:3980-3986
19. Farajnia S, Alikhani MY, Ghotaslou R et al (2009) Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis 13:140-144
20. Campillo B, Dupeyron C, Richardet JP (2001) Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 127:443-450
21. Wagenlehner FM, Pilatz A, Naber KG et al (2008) Anti-infective treatment of bacterial urinary tract infections. Curr Med Chem 15:1412-1427
22. Amano T, Matsui F, Takashima H et al (2003) Analysis of patients with septic shock due to urosepsis brought on by ureteral calculi. Hinyokika Kiyo 49:1-4
23. Savas L, Guvel S, Onlen Y et al (2006) Nosocomial urinary tract infections: micro-organisms, antibiotic sensitivities and risk factors. West Indian Med J 55:188-193
24. Ludwig E (2008) Urinary tract infections in diabetes mellitus. Orv Hertil 149:597-600
25. Houdouin V, Bonacorsi S, Bidet P et al (2006) Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J Antimicrob Chemother 58:748-751
26. Tambyah PA, Oon J (2012) Catheter-associated urinary tract infection. Curr Opin Infect Dis 25:365-370